2014
DOI: 10.1111/tri.12290
|View full text |Cite
|
Sign up to set email alerts
|

Patient with liver dysfunction while maintained on veno-venous extracorporeal membrane oxygenation should not be overlooked as a potential donor

Abstract: Summary This report describes transplantation of liver allograft from a circulatory death donor who was supported by veno‐venous extracorporeal membrane oxygenation (ECMO) for 14 days and presented with severely altered liver functions. Successful liver transplant was done in a patient with hepatocellular carcinoma (HCC) in the background of primary sclerosing cholangitis. There was immediate graft function and uneventful recovery with stable graft function at 1‐year follow‐up. This case illustrates the abilit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…Therapeutically intended ECMO therapy before declaration of death has not been considered a contraindication for organ donation. It has shown comparable results to conventional graft procurement under heart beating conditions [46,47]. Initiating ECMO recirculation directly after controlled cardiac arrest in an intensive care unit setting has been described by Magliocca et al from the University of Michigan [48].…”
Section: Normothermic In Situ Reperfusion In Clinical Settingsmentioning
confidence: 99%
“…Therapeutically intended ECMO therapy before declaration of death has not been considered a contraindication for organ donation. It has shown comparable results to conventional graft procurement under heart beating conditions [46,47]. Initiating ECMO recirculation directly after controlled cardiac arrest in an intensive care unit setting has been described by Magliocca et al from the University of Michigan [48].…”
Section: Normothermic In Situ Reperfusion In Clinical Settingsmentioning
confidence: 99%